Live Breaking News & Updates on 89bio

Stay updated with breaking news from 89bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Analysts Set 89bio, Inc. (NASDAQ:ETNB) PT at $29.00

Shares of 89bio, Inc. (NASDAQ:ETNB – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the seven research firms that are currently covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month […] ....

United States , Dekabank Deutsche Girozentrale , Rohan Palekar , Vanguard Group Inc , Charles Schwab Investment Management Inc , Westfield Capital Management Co , Securities Exchange Commission , Cantor Fitzgerald , Get Free Report , Director Ra Capital Management , Exchange Commission , Schwab Investment Management , Capital Management , Bank Deutsche Girozentrale , Vanguard Group , Get Free , Nasdaq Etnb ,

Head-To-Head Survey: 89bio (NASDAQ:ETNB) versus 2seventy bio (NASDAQ:TSVT)

89bio (NASDAQ:ETNB – Get Free Report) and 2seventy bio (NASDAQ:TSVT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends. Profitability This table compares 89bio and 2seventy bio’s […] ....

United Kingdom , United States , San Francisco , Bristol Myers Squibb Company , Get Free Report , Bristol Myers Squibb , Nasdaq Etnb , Stock Comparison , Stock Analysis ,

89bio, Inc. (NASDAQ:ETNB) Receives $28.83 Consensus Target Price from Analysts

89bio, Inc. (NASDAQ:ETNB – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six brokerages that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month price target among […] ....

Rohan Palekar , Securities Exchange Commission , Westfield Capital Management Co , Alpine Global Management , Charles Schwab Investment Management Inc , Company Profile , Marshall Wace , Eagle Asset Management Inc , Royal Bank , Cantor Fitzgerald , Get Free Report , Marketbeat Ratings , Director Ra Capital Management , Exchange Commission , Schwab Investment Management , Capital Management , Asset Management , Get Free , Nasdaq Etnb ,

89bio (NASDAQ:ETNB) Stock Rating Reaffirmed by HC Wainwright

89bio (NASDAQ:ETNB – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $31.00 price objective on the stock. HC Wainwright’s price target would suggest a potential upside of 171.45% from the […] ....

Rohan Palekar , Alpine Global Management , Cantor Fitzgerald , Charles Schwab Investment Management Inc , Company Profile , Marshall Wace , Securities Exchange Commission , Royal Bank , Eagle Asset Management Inc , Westfield Capital Management Co , Get Free Report , Director Ra Capital Management , Exchange Commission , Schwab Investment Management , Capital Management , Asset Management , Nasdaq Etnb , Reiterated Rating , Hc Wainwright ,

Eagle Asset Management Inc. Boosts Stock Position in 89bio, Inc. (NASDAQ:ETNB)

Eagle Asset Management Inc. lifted its position in 89bio, Inc. (NASDAQ:ETNB – Free Report) by 8.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 712,898 shares of the company’s stock after acquiring an additional 57,092 shares during the period. Eagle Asset Management Inc.’s holdings in […] ....

Eagle Asset Management Inc , Royal Bank , Campbell Co Investment Adviser , Company Profile , Us Bancorp , Eagle Asset Management , Free Report , Asset Management , Forest Capital Management , Rhumbline Advisers , Visit Holdingschannel , Nasdaq Etnb , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,